BE637726A - - Google Patents

Info

Publication number
BE637726A
BE637726A BE637726DA BE637726A BE 637726 A BE637726 A BE 637726A BE 637726D A BE637726D A BE 637726DA BE 637726 A BE637726 A BE 637726A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of BE637726A publication Critical patent/BE637726A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE637726D 1962-09-26 BE637726A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4226162 1962-09-26

Publications (1)

Publication Number Publication Date
BE637726A true BE637726A (en:Method)

Family

ID=12631077

Family Applications (1)

Application Number Title Priority Date Filing Date
BE637726D BE637726A (en:Method) 1962-09-26

Country Status (4)

Country Link
US (1) US3284298A (en:Method)
BE (1) BE637726A (en:Method)
FR (1) FR3021M (en:Method)
GB (1) GB999739A (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
EP1778213B1 (en) * 2004-07-16 2017-04-05 BTG International Limited A method for the synthesis of oligomeric compounds
US7485743B2 (en) * 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds
EP1778212A4 (en) * 2004-07-23 2010-12-08 Btg Int Ltd SACCHARIDES CETOGENES
DK1796658T3 (en) * 2004-09-21 2016-06-27 Btg Int Ltd dopaminergic mimetics
US20070197645A1 (en) * 2004-09-21 2007-08-23 Martin Keith F Treatment of adhd

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2830087A (en) * 1955-02-21 1958-04-08 Hoechst Ag beta-hydroxybutyric acid para-phenetidide and a process for preparing it

Also Published As

Publication number Publication date
FR3021M (fr) 1964-12-21
US3284298A (en) 1966-11-08
GB999739A (en) 1965-07-28

Similar Documents

Publication Publication Date Title
FI43107B (en:Method)
BE627192A (en:Method)
BE627166A (en:Method)
BE626611A (en:Method)
BE626316A (en:Method)
BE626181A (en:Method)
BE634228A (en:Method)
BE634183A (en:Method)
BE625466A (en:Method)
BE633643A (en:Method)
BE623405A (en:Method)
BE632989A (en:Method)
BE631621A (en:Method)
BE629806A (en:Method)
BE629397A (en:Method)
BE628979A (en:Method)
BE623301A (en:Method)
BE627463A (en:Method)
BE621944A (en:Method)
BE626954A (en:Method)
BE626711A (en:Method)
BE637358A (en:Method)
BE631111A (en:Method)
BE621877A (en:Method)
BE628704A (en:Method)